Potassium channel inhibitors
Details for Australian Patent Application No. 2007209981 (hide)
International Classifications
Event Publications
17 July 2008 PCT application entered the National Phase
PCT publication WO2007/089735 Priority application(s): WO2007/089735
28 January 2010 Alteration of Name
The name of the applicant has been altered to Merck Sharp & Dohme Corp.
24 November 2011 Application Accepted
Published as AU-B-2007209981
22 March 2012 Standard Patent Sealed
11 October 2012 Alteration of Name
The name of the patentee has been altered to Merck Sharp & Dohme Corp.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2007209992-Crystalline forms of a farnesyl dibenzodiazepinone
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser